Article

FDA OKs epikeratome device for Epi-LASIK

Atlanta-CIBA Vision Corp. will begin marketing its Centurion SES EpiEdge epikeratome for the Epi-LASIK refractive procedure this fall now that it has obtained U.S. regulatory approval.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
Related Content
EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment
May 14th 2025

EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Living with GA: How patients in the US and Western Europe cope
May 14th 2025

Living with GA: How patients in the US and Western Europe cope

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Hypoglycemia may promote a breakdown of the blood-retinal barrier
May 13th 2025

Hypoglycemia may promote a breakdown of the blood-retinal barrier

Potentially hazardous eye care products recalled nationwide
May 12th 2025

Potentially hazardous eye care products recalled nationwide

© 2025 MJH Life Sciences

All rights reserved.